Arena Joins Vivus Finding Obesity Drugs Fizzle on Costs

Arena Joins Vivus Finding Obesity Drugs Fizzle on Costs

Sandy Huffaker/Bloomberg

Short sales against Arena Pharmaceuticals Inc. have risen this year, reaching 21 percent of shares outstanding as of March 8, the most since March 2011.